SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma
Authors:
- 1 March 2013
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 26 (3) , 393-403
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastomaBMC Cancer, 2012
- DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosisEuropean Journal of Medical Research, 2012
- EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFRCancer Research, 2012
- Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implicationsBMC Medicine, 2011
- Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2Cell Cycle, 2009
- The SWI/SNF complex and cancerOncogene, 2009
- Repression of E-cadherin by the polycomb group protein EZH2 in cancerOncogene, 2008
- Gene-promoter hypermethylation as a biomarker in lung cancerNature Reviews Cancer, 2004
- Role of Histone H3 Lysine 27 Methylation in Polycomb-Group SilencingScience, 2002
- No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumorsGenes, Chromosomes and Cancer, 2002